(Q44304788)

1 December 2017

title

Rho-kinase inhibition with intracoronary fasudil prevents myocardial ischemia in patients with coronary microvascular spasm (English)

1 reference

1 December 2017

0 references

0 references

1 reference

Masahiro Mohri

1

1 reference

1 December 2017

Hiroaki Shimokawa

2

1 reference

1 December 2017

Yoji Hirakawa

3

1 reference

1 December 2017

Akihiro Masumoto

4

1 reference

1 December 2017

Akira Takeshita

5

1 reference

1 December 2017

language of work or name

English

0 references

publication date

1 January 2003

1 reference

Journal of the American College of Cardiology

1 December 2017

published in

1 reference

1 December 2017

volume

41

1 reference

1 December 2017

issue

1

1 reference

1 December 2017

page(s)

15-19

1 reference

Cardiac syndrome X: clinical characteristics and left ventricular function. Long-term follow-up study

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902632-3

7 January 2021

Angina pectoris and normal coronary arteriograms: clinical presentation and hemodynamic characteristics

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902632-3

7 January 2021

Dynamic limitation of coronary vasodilator reserve in patients with dilated cardiomyopathy and chest pain.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902632-3

7 January 2021

Coronary artery infusion of neuropeptide Y in patients with angina pectoris

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902632-3

7 January 2021

Angina pectoris caused by coronary microvascular spasm

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902632-3

7 January 2021

Signal transduction by G-proteins, rho-kinase and protein phosphatase to smooth muscle and non-muscle myosin II.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902632-3

7 January 2021

Rho-kinase as a novel therapeutic target in treatment of cardiovascular diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902632-3

7 January 2021

Rho-kinase-mediated pathway induces enhanced myosin light chain phosphorylations in a swine model of coronary artery spasm

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902632-3

7 January 2021

Inhibition of myosin phosphatase by upregulated rho-kinase plays a key role for coronary artery spasm in a porcine model with interleukin-1beta

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902632-3

7 January 2021

Suppression of coronary artery spasm by the Rho-kinase inhibitor fasudil in patients with vasospastic angina

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902632-3

7 January 2021

Coronary microvascular spasm causes myocardial ischemia in patients with vasospastic angina

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902632-3

7 January 2021

Cigarette smoking is a major risk factor for coronary spasm

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902632-3

7 January 2021

Bradykinin-Induced Vasodilation Is Impaired at the Atherosclerotic Site but Is Preserved at the Spastic Site of Human Coronary Arteries In Vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902632-3

7 January 2021

Role of nitric oxide in substance P-induced vasodilation differs between the coronary and forearm circulation in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902632-3

7 January 2021

Therapeutic options for the management of patients with cardiac syndrome X.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902632-3

7 January 2021

Atenolol versus amlodipine versus isosorbide-5-mononitrate on anginal symptoms in syndrome X

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902632-3

7 January 2021

Three-year follow-up of the Japanese patients with microvascular angina attributable to coronary microvascular spasm

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902632-3

7 January 2021

Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902632-3

7 January 2021

Possible involvement of Rho-kinase in the pathogenesis of hypertension in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902632-3

7 January 2021

Inhibition of Rho-associated kinase blocks agonist-induced Ca2+ sensitization of myosin phosphorylation and force in guinea-pig ileum

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902632-3

7 January 2021

Rho-kinase inhibitors prevent agonist-induced vasospasm in human internal mammary artery

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902632-3

7 January 2021

Enhanced myosin light chain phosphorylations as a central mechanism for coronary artery spasm in a swine model with interleukin-1beta

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902632-3

7 January 2021

Local effect of serotonin released during coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902632-3

7 January 2021

Coronary vasoconstriction during myocardial ischemia induced by rises in metabolic demand in patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902632-3

7 January 2021

Anti-anginal effect of fasudil, a Rho-kinase inhibitor, in patients with stable effort angina: a multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902632-3

7 January 2021

10.1016/S0735-1097(02)02632-3

Identifiers

DOI

1 reference

1 December 2017

1 reference